Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs

Pharmaceutical Research

Volumn 20, Issue 2, 2003, Pages 264-269

  Lee, Philip J ^a   Langer, Robert ^a   Shastri, V Prasad ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemical enhancers; Microemulsion; N methyl pyrrolidone; Transdermal drug delivery

Indexed keywords

DILTIAZEM; ESTRADIOL; LIDOCAINE; N METHYLPYRROLIDONE; NONIONIC SURFACTANT; OIL; OLEYL ALCOHOL; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; WATER;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; EFFUSION; HUMAN; HUMAN TISSUE; HYDROPHILICITY; HYDROPHOBICITY; MICROEMULSION; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; HYDROPHOBICITY; MICROSPHERES; PHARMACEUTICAL PREPARATIONS;

EID: 0037332058     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022283423116     Document Type: Article

References (25)

1. R. P. Bagwe, J. R. Kanicky, B. J. Palla, P. K. Patanjali, and D. O. Shah. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Crit. Rev. Ther. Drug Carrier Syst. 18:77-140 (2001).
2. M. Trotta, M. R. Gasco, and S. Morel. Release of drugs from oil-water microemulsions. J. Control. Release 10:237-243 (1989).
3. M. Trotta, F. Pattarino, and M. R. Gasco. Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharm. Acta Helv. 71:135-140 (1996).
4. D. W. Osborne, A. J. Ward, and K. J. O'Neill. Microemulsions as topical drug delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug. J. Pharm. Pharmacol. 43:451-454 (1991).
5. H-O. Ho, C-C. Hsiao, and M-T. Sheu. Preparation of microemulsions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs. J. Pharm. Sci. 85:138-143 (1996).
6. J. Guo, Q. Ping, G. Sun, and C. Jiao. Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int. J. Pharm. 194:201-207 (2000).
7. Q. Zhang, G. Yie, Y. Li, Q. Yang, and T. Nagai. Studies on the cyclosporin A loaded stearic acid nanoparticles. Int. J. Pharm. 200:153-159 (2000).
8. M. E. Baca-Estrada, M. Foldvari, C. Ewen, I. Badea, and L. A. Babiuk. Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system. Vaccine 18:1847-1854 (2000).
9. K. A. Walters, P. H. Dugard, and A. T. Florence. Non-ionic surfactants and gastric mucosal transport of paraquat. J. Pharm. Pharmacol. 33:207-213 (1981).
10. P. P. Sarpotdar and J. L. Zatz. Evaluation of penetration enhancement of lidocaine by nonionic surfactants through hairless mouse skin in vitro. J. Pharm. Sci. 75:176-181 (1986).
11. M. L. Francoeur, G. M. Golden, and R. O. Potts. Oleic acid: its effects on stratum corneum in relation to (trans)dermal drug delivery. Pharm. Res. 7:621-627 (1990).
12. D. D. Kim and Y. W. Chien. Transdermal delivery of dideoxy-nucleoside-type anti-HIV drugs: the effect of vehicle and enhancer on skin permeation. J. Pharm. Sci. 85:214-219 (1996).
13. H. Sasaki, M. Kojima, J. Nakamura, and J. Shibasaki. Enhancing effect of combining two pyrrolidone vehicles on transdermal drug delivery. J. Pharm. Pharmacol. 42:196-199 (1990).
14. C. A. Phillips and B. B. Michniak. Transdermal delivery of drugs with differing lipophilicities using azone analogs as dermal penetration enhancers. J. Pharm. Sci. 84:1427-1433 (1995).
15. K. Yoneto, S. K. Li, A. H. Ghanem, D. J. Crommelin, and W. I. Higuchi. A mechanistic study of the effects of the 1-alkyl-2-pyrrolidones on bilayer permeability of stratum corneum lipid liposomes: a comparison with hairless mouse skin studies. J. Pharm. Sci. 84:853-860 (1995).
16. M. E. Johnson, S. Mitragotri, A. Patel, D. Blankschtein, and R. Langer. Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery. J. Pharm. Sci. 85:670-679 (1996).
17. M. E. Johnson, D. Blankschtein, and R. Langer. Permeation of steroids through human skin. J. Pharm. Sci. 84:1144-1146 (1995).
18. Y. W. Chien, T. Y. Chien, R. E. Bagdon, Y. C. Huang, and R. H. Bierman. Transdermal dual-controlled delivery of contraceptive drugs: formulation development, in vitro and in vivo evaluations, and clinical performance. Pharm. Res. 12:1000-1010 (1989).
19. M. S. Powers, L. Schenkel, P. E. Darley, W. R. Good, J. C. Balestra, and V. A. Place. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement. Am. J. Obstet. Gynecol. 152:1099-1106 (1985).
20. P. D. Huibers. Surfactant Self-Assembly, Kinetics and Thermodynamics of Micellar and Microemulsion Systems. Ph.D. Thesis, University of Florida, 1996.
21. S. Mitragotri, M. E. Johnson, D. Blankschtein, and R. Langer. An analysis of the size selectivity of solute partitioning, diffusion, and permeation across lipid bilayers. Biophys. J. 77:1268-1283 (1999).
22. S. R. Gorukanti, L. Li, and K. H. Kim. Transdermal delivery of antiparkinsonian agent, benztropine. Int. J. Pharm. 192:159-172 (1999).
23. S. D. Roy, E. Roos, and K. Sharma. Transdermal delivery of buprenorphine through cadaver skin. J. Pharm. Sci. 83:126-130 (1994).
24. K. D. Peck, A. H. Ghanem, and W. I. Higuchi. The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membranes. J. Pharm. Sci. 84:975-982 (1995).
25. th Edition. Medical Economics Co. Montvale, New Jersey, p 1016 (2002).